Ignite Creation Date:
2025-12-25 @ 4:38 AM
Ignite Modification Date:
2026-01-10 @ 12:26 AM
Study NCT ID:
NCT03242018
Status:
COMPLETED
Last Update Posted:
2021-06-25
First Post:
2017-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control
Sponsor:
Lexicon Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EFC15166
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |